{"id":90088,"date":"2024-07-08T08:20:08","date_gmt":"2024-07-08T08:20:08","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/07\/08\/new-pill-can-increase-chances-of-ivf-success-study-finds\/"},"modified":"2024-07-08T08:20:09","modified_gmt":"2024-07-08T08:20:09","slug":"new-pill-can-increase-chances-of-ivf-success-study-finds","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/07\/08\/new-pill-can-increase-chances-of-ivf-success-study-finds\/","title":{"rendered":"New pill can increase chances of IVF success, study finds"},"content":{"rendered":"
\"New<\/div>


\n<\/p>\n

\n

A pill for couples struggling to conceive with IVF treatment has been found to increase the chances of pregnancy, scientists say.<\/p>\n

Researchers said initial trials of the drug – known as OXO-001 and created by Spanish biotech company Oxolife – showed “promising” results.<\/p>\n

It acts directly on the inner lining of the womb to improve the embryo implantation process during fertility treatment.<\/p>\n

Around 96 infertile women who were aged 40 or under and were receiving fertility treatment – either IVF or intracytoplasmic sperm injection (ICSI) with donor eggs – at 28 centres across Europe took part in the new study, between September 2021 and January 2023.<\/p>\n

They were either given a placebo or OXO-001 – taken twice daily, one menstrual cycle before the embryo transfer and five weeks after.<\/p>\n

Researchers found “ongoing pregnancy rates” measured 10 weeks after embryo transfer were 46.3% for patients treated with OXO-001 – compared with 35.7% for those given a placebo.<\/p>\n

\n
\n
\n <\/source><\/source><\/picture>\n <\/div>\n
\n Follow Sky News on WhatsApp<\/span><\/p>\n

Keep up with all the latest news from the UK and around the world by following Sky News<\/p>\n

Tap here<\/a>\n <\/div>\n<\/p><\/div>\n<\/p><\/div>\n

This is a “clinically significant finding”, they said, presenting their study to the European Society of Human Reproduction and Embryology’s (ESHRE) 40th annual meeting in Amsterdam.<\/p>\n

They said there was also a clinically meaningful increase in the number of women who went on to have a live birth.<\/p>\n

The live birth rate was 42.6% for women who took the new pill compared with 35.7% among those who took the placebo, according to the study – also being published in the journal Human Reproduction.<\/p>\n

Women in both groups suffered similar side-effects including headaches, nausea, vomiting, gastrointestinal issues and dizziness – most of which were mild to moderate.<\/p>\n

The drug had already gone through safety checks in early studies – known as pre-clinical trials.<\/p>\n

It is now to be tested on a larger group of women, including those who are using their own eggs.<\/p>\n

<\/p>\n

<\/a><\/p>\n

Read more from Sky News:<\/strong>
Ethnic disparities in baby mortality rates<\/a><\/strong>
Scientists attach living skin to robots<\/a><\/strong><\/p>\n

Oxolife chief executive Dr Agnes Arbat said: “Most rounds of IVF or ICSI still end in failure – many because a viable embryo does not implant.<\/p>\n

“A simple-to-take pill that materially improves the chance of success would therefore be of huge benefit to those who want a baby. This proof-of-concept phase two study shows that hope is now a step closer.”<\/p>\n

She added: “This study was purposefully designed to include only women who used donor eggs so it could single out the true effect of OXO-001 on the endometrium.<\/p>\n

“However, we believe OXO-001 has the potential to work equally well in those using their own eggs, and we are already planning a pivotal phase three clinical trial in this more extensive group to support product registration.”<\/p>\n<\/p><\/div>\n


\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A pill for couples struggling to conceive with IVF treatment has been found to increase the chances of pregnancy, scientists say. Researchers said initial trials of the drug – known as OXO-001 and created by Spanish biotech company Oxolife – showed “promising” results. It acts directly on the inner lining of the womb to improve […]<\/p>\n","protected":false},"author":2,"featured_media":90089,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/e3.365dm.com\/24\/03\/512x512\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[25371,2302,3631,8284,14931,250,4239],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/90088"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=90088"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/90088\/revisions"}],"predecessor-version":[{"id":90090,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/90088\/revisions\/90090"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/90089"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=90088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=90088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=90088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}